Colorectal polyps in the elderly: What should be done?

Drugs and Aging

Volumn 19, Issue 6, 2002, Pages 393-404

  Miller, Kenneth ^a   Waye, Jerome D ^a,b  

^a MOUNT SINAI HOSPITAL   (United States)

^b 650 Park Ave ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; BETA CAROTENE; EFLORNITHINE; FOLIC ACID; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; SULINDAC SULFONE; TOCOPHEROL; URSODEOXYCHOLIC ACID;

AGED; AGING; CHEMOPROPHYLAXIS; COLON ADENOMA; COLON POLYP; COLONOSCOPY; DIET; GROWTH RATE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECTUM ADENOMA; RECTUM POLYP; REVIEW; RISK FACTOR;

EID: 0036352639     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200219060-00001     Document Type: Review

References (82)

1. Cancer statistics, 1994
2. Colorectal cancer update: Prevention, screening, treatment and surveillance for high risk groups
3. Gastrointestinal malignancies
4. Randomized, controlled trial of faecal occult blood screening for colorectal cancer
5. Randomized study for colorectal cancer with faecal-occult blood test
6. Reduced mortality from colorectal cancer by screening for fecal occult blood
7. Screening for colorectal cancer
8. A case-control study of screening colonoscopy and mortality from colorectal cancer
9. Prevention of colorectal cancer by flexible sigmoidoscopy and polypectomy: A case-control study of 32,702 veterans
10. The prevention of invasive cancer of the rectum
11. Prevention of colorectal cancer by colonoscopic polypectomy
12. Population based surveillance by colonoscopy: Effect on the incidence of colorectal cancer
13. Screening for colorectal cancer
14. Congress passes medicare recoupment bill
15. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender, and family history
16. Colon cancer screening: Sigmoidoscopy or colonoscopy
17. Polyps and cancer of the large bowel. A necropsy study in Liverpool
18. Screening for colon cancer: A review of current and future strategies
19. Prospective study of the frequency and size distribution of polyps missed by colonoscopy
20. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies
21. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps
22. An initial experience with screening for colon polyps using spiral CT with and without CT colography
23. Incidence and recurrence rates of colorectal adenomas: A prospective study
24. Colonic adenomas: Prevalence and incidence rates, growth rates, and miss rates at colonoscopy
25. Two-year incidence of colon adenomas developing after tandem colonoscopy
26. Approach to colon polyps in the elderly
27. Natural history of untreated colonic polyps
28. Temporal sequence of evolving colorectal cancer from the normal colon
29. How often should patients be sigmoidoscoped? A mathematical perspective
30. Growth of colorectal polyps: Redetection and evaluation of unresected polyps for a period of three years
31. The National Polyp Study: Patient and polyp characteristics associated with high grade dysplasia in colorectal adenomas
32. Appropriate intervals for surveillance
33. Treatment of small colorectal polyps: A population based study of the risk of subsequent carcinoma
34. Colorectal polyps and the risk of subsequent carcinoma
35. Long term risk of colorectal cancer after excision of rectosigmoid adenomas
36. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up
37. Adenoma size and number are predictive of adenoma recurrence: Implications for surveillance colonoscopy
38. Adenoma characteristics as risk factors for recurrence of advanced adenomas
39. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps
40. A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma Follow-up Study
41. Significance of a normal surveillance colonoscopy in patients with a history of adenomatous polyps
42. Chemoprevention of colorectal cancer
43. Antiproliferative effect of nonsteroidal anti-inflammatory drugs against human colon cancer cells
44. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenoma
45. Aspirin and the risk of colorectal cancer in women
46. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer
47. Effect of aspirin and nonsteroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham Faecal Occult Blood Screening Programme
48. Aspirin and the other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals
49. Reduced risk of large bowel adenomas among aspirin users
50. Aspirin use and chronic diseases: A cohort study of the elderly
51. Low dose aspirin and incidence of colorectal tumors in a randomized trial
52. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
53. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
54. Sulindac for polyposis of the colon
55. Rectal cancer in FAP patient after sulindac
56. NSAID effect on sporadic colonic polyps
57. Effect of sulindac on sporadic colorectal adenomatous polyps
58. Effect of sulindac on sporadic colonic polyps
59. Nonsteroidal anti-inflammatory drugs and sporadic colorectal adenomas
60. Nonsteroidal anti-inflammatory drugs and cancer prevention
61. Induction of colon cancer cell apoptosis in vitro and inhibition of intestinal tumor formation in Min/+Mice by balsalazide and metabolites
62. Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel
63. Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
64. Long term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: A retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire
65. Diet and risk of colorectal adenomas: Macronutrients, cholesterol, and fiber
66. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women
67. Lack of effect of a high fiber cereal supplement on the recurrence of colorectal adenomas
68. Lack of effect of a low fat, high fiber diet on the recurrence of colorectal adenomas
69. A clinical trial of antioxidant vitamins to prevent colorectal adenoma
70. Calcium supplements for the prevention of colorectal adenomas
71. Folate, methionine, and alcohol intake and risk for colorectal adenoma
72. Folate intake, alcohol consumption and cigarette smoking and risk of colorectal adenomas
73. Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis
74. Postmenopausal hormone and the risk of colorectal adenoma and cancer
75. Chemo- and dietary prevention of colorectal cancer
76. Dose de- escalation chemoprevention trial of ∝ difluoromethylornithine in patients with colon polyps
77. Chemoprevention of azoxymethanei induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid
78. Colonic mucosal proliferation is related to serum deoxycholic acid levels
79. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis
80. Aspirin as Prophylaxis against colorectal cancer
81. Nonsteroidal anti-inflammatory agents in chemoprevention of colorectal cancer: At what cost?
82. Non-steroidal anti-inflammatory drugs and ulcer complications: A risk factor analysis for clinical decision making